← Back to Search

Behavioral Intervention

Cognitive Support Program for Brain Cancer

N/A
Waitlist Available
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline; 2 months (0-2 weeks post-training); 5 months (3 months post-training)
Awards & highlights

Study Summary

This study evaluates the feasibility and preliminary efficacy of a brief cognitive-behavioural program designed to improve cognitive functioning in people with brain metastases.

Eligible Conditions
  • Brain Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline; 2 months (0-2 weeks post-training); 5 months (3 months post-training)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline; 2 months (0-2 weeks post-training); 5 months (3 months post-training) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Functional Assessment of Cancer Therapy - Cognitive
Secondary outcome measures
BADS Zoo Map Test
Controlled Oral Word Association Test
Frontal Systems Behavior Scale
+7 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cognitive Support ProgramExperimental Treatment1 Intervention
Three individual sessions of supportive psychoeducation, mindfulness practice, and strategy training (e.g., strategies to improve memory or concentration), with practice applying program content between sessions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Support Program
2017
N/A
~20

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,476 Previous Clinical Trials
485,162 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby May 2025